2024-517779-19-00CompletedPhase 1
A study to evaluate the safety, tolerability and distribution of TB0010 in head and neck squamous cell carcinoma
Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Oct 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- First submitted
- 10 Oct 2024
- Start date
- 5 Jan 2024
- Lead sponsor
- Tenboron Oy
- Diseases
- Head and neck cancer
- EU CT number
- 2024-517779-19-00
- EudraCT number
- 2019-000273-22
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 6
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HUS-Yhtymae | Helsinki | Finland | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.